NCT00909012 Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria Status COMPLETED Phase NA
NCT00892554 The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU) Status COMPLETED Phase NA
NCT00841100 Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response Status COMPLETED Phase PHASE2
NCT00838435 Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU Status COMPLETED Phase PHASE3
NCT00827762 Behavioral Effects of Kuvan in Children With Mild Phenylketonuria Status TERMINATED Phase N/A
NCT00789568 A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT00778206 PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry Status COMPLETED Phase N/A
NCT00728676 Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors Status COMPLETED Phase N/A
NCT00688844 Nutritional and Neurotransmitter Changes in PKU Subjects on BH4 Status COMPLETED Phase N/A
NCT00634660 Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria Status COMPLETED Phase PHASE1
NCT00332189 Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006 Status COMPLETED Phase PHASE3
NCT00309400 The Early History of Universal Screening for Metabolic Disorders Status COMPLETED Phase N/A
NCT00006142 Study of a Phenylalanine Restricted Diet During Pregnancy to Prevent Symptoms in Offspring of Patients With Phenylketonuria Status COMPLETED Phase NA